Skip to content

USPTO Proposes Rule and Director Implements Policy Likely to Limit Multiple Patent Validity Challenges Ted M. Cannon On Friday, October 17, the USPTO published a proposed rule that, if implemented, would likely…

  Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing In Us Inventor, Inc. v. United States Patent And Trademark Office, Appeal No. 24-1396, the Federal…

NASA’s Breakthrough Superalloy Wins Commercial Invention of the Year Ningxi Sun NASA Glenn Research Center’s new material, GRX-810, has been recognized as the Commercial Invention of the Year by NASA’s Inventions and Contributions…

Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing Jacob R. Rosenbaum & Jordan A. DeOrio US INVENTOR, INC. v. UNITED STATES PATENT AND TRADEMARK OFFICE Before Lourie, Reyna,…

USPTO, JPO, and EPO Meet to Discuss Global IP Challenges Joseph Mallon, Ph.D. & Ashley C. Morales Beginning on October 20, 2025, recently confirmed United States Patent and Trademark Office (USPTO) Director…

In a recent interview with Federal News Network, Knobbe Martens partner Jarom Kesler provided insights into the impact of the government shutdown on intellectual property law, including how the United…

Firm receives ‘Tier 1’ national and regional rankings for litigation, patent and trademark work IRVINE, Calif., November 6, 2025 – Knobbe Martens has once again been recognized as a top-tier…

In their latest Law360 column discussing noteworthy Federal Circuit cases, partners Jeremiah Helm and Sean Murray examine the recent decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., and how…

Agreement will support the development and commercialization of non-opioid therapy for postsurgical pain control IRVINE, Calif., November 4, 2025 – A team from Knobbe Martens advised Pacira BioSciences, Inc. in…

IRVINE, Calif., October 29, 2025 –  Knobbe Martens is pleased to announce the firm has obtained a significant appellate victory for Edwards Lifesciences in a high-stakes patent infringement dispute involving…

Older posts